Chemical Screening, Metabolomics and Proteomics Facility

The CeMM chemical biology platforms enable the identification and characterization of bioactive small molecules, metabolites and proteins. State-of-the art infrastructure and technological expertise ensures optimal support of collaborating researchers to characterize the molecular mechanism of action of drugs, develop new chemical probes, and quantitate the protein and metabolite targets of intracellular biochemical pathways. 

Send an e-mail

Stefan Kubicek
Head of Chemical Screening, Proteomics and Metabolomics Facility